TM4SF5, as a physiological sensor of lysosomal arginine in liver cancer cells, contributes to the SLC38A9-dependent efflux of arginine, so anti-TM4SF5 reagents could be used as a strategy for impairing arginine auxotrophs in HCC [57,61,62]. The gene discussed is TM4SF5; the disease is hepatocellular carcinoma.